Print page content Print
Increase text size Decrease text size
Text Size

VANGUARD® Rapid Resp 3 Intranasal

Canine Infectious Respiratory Disease (CIRD) Background

Infectious respiratory disease in the dog is multifactorial, both bacterial and viral pathogens are frequently observed. The clinical signs will often be identical regardless of the infecting pathogen.  Additionally, when respiratory diagnostic testing is performed in symptomatic dogs co-infections are often observed.  The presence of multiple pathogens may lead to more severe symptoms. A multivalent immunization protocol can help PREVENT THE PREVENTABLE.

Collapse All
    • Vanguard Rapid Resp 3 Intranasal helps protect dogs from three pathogens associated with Canine Infectious Respiratory Disease (CIRD).
    • Single-nostril (0.5 mL) respiratory vaccine that helps make administration fast and comfortable
    • Intranasal administration via syringe 
  • For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing respiratory disease caused by canine adenovirus type 2 (CAV-2), canine parainfluenza caused by canine parainfluenza virus (CPiV) and disease caused by Bordetella bronchiseptica.

    Also available in bivalent (Bb and CPiV) and monovalent (Bb) options.



We are Mon–Fri, 8am–8pm ET

email to

This site is intended for U.S. Animal Healthcare Professionals.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2019 Zoetis Services LLC. All rights reserved.